As of Feb 21, 2025, Ambev S.A. Intrinsic Value is $2.8. This suggests it may be undervalued by 45.9% compared to its current price of around $1.9.
As of Feb 21, 2025, Ambev S.A.'s Discounted Cash Flow (DCF) valuation estimates its share price at $3.2. This suggests it may be overvalued by 66.8% to its current price of around $1.9, using a discount rate of 12.0% and terminal growth rate of 2.0%.
Ambev S.A. is currently considered undervalued based on its Discounted Cash Flow (DCF) valuation and Relative Valuation, which estimates its share price to be $2.8, compared to a market price of around $1.9. This suggests a potential undervaluation of 45.9%.